Dermatology NewsFDA Approves Ustekinumab Biosimilar Steqeyma, the Seventh of Its KindDecember 19, 2024Psoriatic ArthritisPsoriasis
Dermatology NewsFDA Approves Cosibelimab for Cutaneous SCCDecember 17, 2024Nonmelanoma Skin CancerBusiness of Medicine
Dermatology NewsNew Cause of Sexually Transmitted Fungal Infection Reported in MSMNovember 13, 2024Infectious Diseases
Dermatology NewsBimekizumab Gains FDA Approval for Psoriatic Arthritis, Axial SpondyloarthritisSeptember 24, 2024Psoriatic ArthritisPsoriasis
Dermatology NewsFDA OKs Subcutaneous Atezolizumab Formulation for Multiple Cancer IndicationsSeptember 17, 2024Mixed TopicsMelanomaPractice Management
Dermatology NewsFDA Approves Lymphir for R/R Cutaneous T-Cell LymphomaAugust 9, 2024Business of MedicinePractice Management
Dermatology NewsFDA Approves First Engineered Cell Therapy for a Solid TumorAugust 2, 2024Nonmelanoma Skin CancerPractice ManagementRare DiseasesMelanomaBusiness of Medicine
Dermatology NewsPyzchiva Receives FDA Approval as Third Ustekinumab BiosimilarJuly 2, 2024Psoriatic ArthritisPediatricsRare DiseasesPsoriasis
Dermatology NewsFDA Expands Repotrectinib Label to All NTRK Gene Fusion+ Solid TumorsJune 14, 2024Practice ManagementMelanomaNonmelanoma Skin Cancer
Dermatology NewsFDA Grants New Pediatric Arthritis Indications for UpadacitinibJune 7, 2024PediatricsRare Diseases
Dermatology NewsBelimumab Autoinjector Approved for Pediatric LupusMay 22, 2024PediatricsRare DiseasesAutoimmune Diseases
Dermatology NewsSecond Ustekinumab Biosimilar Gets FDA ApprovalApril 18, 2024Psoriatic ArthritisPsoriasis
Dermatology NewsMeasles Control So Far in 2024: ‘Not Off to a Great Start’March 25, 2024Infectious DiseasesPediatrics
Dermatology NewsTIL for Melanoma: What Are the Costs and Other Challenges to Getting It to Patients?March 8, 2024MelanomaPractice ManagementBusiness of MedicineMixed Topics
Dermatology NewsOmalizumab for Food Allergies: What PCPs Should KnowMarch 4, 2024UrticariaAtopic DermatitisPediatrics
